Skip to main content
Premium Trial:

Request an Annual Quote

Canada Clears Seegene Diarrhea Test

NEW YORK (GenomeWeb News) – Seegene said today that its PCR-based test for detecting viral diarrhea has been cleared for use in Canada by a government health regulator.

The company’s Seeplex Diarrhea-V ACE Detection test received a Medical Device License from Health Canada.

The company, based in Rockville, Md., and Seoul, Korea, said that the test has already been permitted for use in more than 30 countries recognizing the CE Mark.

The Seeplex is a qualitative in vitro test that rapidly diagnoses a range of viral pathogens, including enteric adenovirus, group A rotavirus, norovirus, and astrovirus.

The Scan

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.